Publicité
Publicité

AEON

AEON logo

AEON Biopharma, Inc.

1.07
USD
Sponsorisé
-0.02
-1.83%
09 janv., 15:46 UTC -5
Fermé
exchange

Après-marché

1.08

+0.01
+0.93%

AEON Rapports sur les bénéfices

Ratio de surprise positive

AEON a dépassé 5 des 7 dernières estimations.

71%

Prochain rapport

Date du prochain rapport
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Variation implicite de Q3 25 (Revenue/ EPS)
--
/
--
Variation implicite de Q-- -1 (Revenue/ EPS)
--
/
--

AEON Biopharma, Inc. earnings per share and revenue

On 14 nov. 2025, AEON reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.43 USD, resulting in a 56.68% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.77% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q3 2025, AEON Biopharma, Inc. reported EPS of -$0.19, beating estimates by 56.68%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.77%, changed from $0.94 before the earnings release to $0.90 the day after.
The next earning report is scheduled for --.
Based on -- analystes, AEON Biopharma, Inc. is expected to report EPS of -- and revenue of -- for Q-- --.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité